Drug-Free Migraine Relief Begins Here
Cefaly (cefaly.com) scores 89 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Technology brands, in the 99th percentile of 18989 Healthcare brands.
Cefaly is an FDA-cleared, drug-free medical device designed to relieve and prevent migraines through trigeminal nerve stimulation. It is sold without a prescription and is eligible for HSA/FSA purchase. The company offers a 90-day risk-free trial and positions its technology as a clinically evidenced, non-pharmaceutical alternative for migraine sufferers and the clinicians who treat them.
| Brand Name | Cefaly |
|---|---|
| Domain | cefaly.com |
| Industry | Healthcare, Technology |
| Main Competitors | Nerivio (77/100), Neurolief (Relivion) (73/100), eNeura (sTMS) (68/100), Quell (72/100), Truvaga (85/100) |
Moz Domain Authority 51/100 vs category average 40 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,330,853 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Cefaly has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "FDA-cleared, drug-free migraine relief & prevention. No prescription needed. HSA/FSA eligible. Try Cefaly risk-free for 90 days." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: PHP, Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, Facebook, Instagram, X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Cefaly?", Claude could identify the brand as of October 2026. Cefaly is a medical device company known for its wearable electrical nerve stimulation (eTNS) headband device used to prevent and treat migraines. It's an FDA-cleared, non-drug alternative for migraine sufferers that uses electrodes placed on the forehead to stimulate the trigemi Best known for The Cefaly headband device, an FDA-cleared external trigeminal nerve stimulation device for migraine prevention and treatment.
When asked "Best brands similar to Cefaly?", Claude would recommend Cefaly as of October 2026. It's one of the most well-known and clinically validated non-drug migraine devices on the market, so it would naturally come up in a discussion of migraine treatment alternatives.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cefaly's main competitors in Healthcare: Nerivio (77/100), Neurolief (Relivion) (73/100), eNeura (sTMS) (68/100), Quell (72/100), Truvaga (85/100).
Sources: Brand Analyzer scan
Cefaly offers a wearable, FDA-cleared nerve stimulation device designed for migraine relief and prevention. The device uses external trigeminal nerve stimulation technology and is available for purchase without a prescription, with HSA/FSA eligibility and a 90-day risk-free trial.
Sources: Cefaly official site
Cefaly is an FDA-cleared, drug-free medical device used for the relief and prevention of migraines. It works through external nerve stimulation and does not require a prescription to purchase.
Sources: Cefaly official site
Cefaly has moderate AI-search visibility, scoring 51/100 on Brand Analyzer's AI visibility composite (visibility 53, trust 40, recommendation 61). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cefaly official site
Cefaly provides nerve stimulation technology that calms the trigeminal nerve, a nerve pathway associated with migraine pain, in order to relieve and prevent migraine attacks without the use of drugs.
Sources: Cefaly official site
Cefaly's trustworthiness is supported by its FDA clearance, which indicates the device has met regulatory standards for safety and effectiveness based on clinical evidence. The company also backs its product with a 90-day risk-free trial, suggesting confidence in its performance, and it is marketed to both patients and clinicians who treat migraines.
Sources: Cefaly official site
Cefaly scores 61/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Cefaly official site
Cefaly is known for being one of the first FDA-cleared, drug-free devices for migraine relief and prevention, offered without a prescription and backed by clinical evidence. It is also known for its 90-day risk-free trial and HSA/FSA eligibility.
Sources: Cefaly official site
Cefaly can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cefaly official site
Cefaly is used by individuals who suffer from migraines and are looking for a drug-free, FDA-cleared treatment option, as well as by clinicians who treat migraine patients and may recommend or use the device in care plans.
Sources: Cefaly official site
Cefaly is popular among migraine sufferers seeking a non-pharmaceutical treatment option because it is FDA-cleared, requires no prescription, and is backed by clinical evidence. Its risk-free 90-day trial and HSA/FSA eligibility also make it an accessible option for those wanting to avoid medication-based migraine treatments.
Sources: Cefaly official site
Cefaly scores 51/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cefaly has a limited AI-visibility profile at 51/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (61/100) and its weakest is trust (40/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,330,853 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Cefaly from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Cefaly: Caring.com (89/100), Care UK (89/100), CeraVe (89/100), CHI Health (89/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.